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Mouse embryonic stem cells (mESCs) cultured under
serum/LIF conditions exhibit heterogeneous expres-
sion of pluripotency-associated factors that can be
overcome by two inhibitors (2i) of the MEK and
GSK3 pathways. Several studies have shown that
the ‘‘ground state’’ induced by 2i is characterized
by global hypomethylation and specific transcrip-
tional profiles, but little is known about the contrib-
uting effectors. Here we show that 2i conditions
rapidly alter the global binding landscape of OCT4,
SOX2, and NANOG. The dynamic binding influences
enhancer activity and shows enrichment for regula-
tors linked to Wnt and Erk signaling. Epigenomic
characterization provided limited insights to the
immediate transcriptional dynamics, suggesting
that these are likely more secondary effects. Like-
wise, loss of the PRC2 component EED to prevent
H3K27me3 deposition had minimal effect on the
transcriptome, implying that it is largely dispensable
for continued repression of bivalent genes and de
novo silencing in 2i.
INTRODUCTION
Under common culture conditions in serum plus Leukemia Inhib-
itory Factor (LIF), mouse embryonic stem cells (ESCs) receive
partially opposing signaling cues, as serum/LIF-induced STAT3
signaling favors the pluripotent state, but does not block the
activation of Fgf/Erk signaling involved in cellular differentiation
(Kunath et al., 2007). To suppress these differentiation cues,
mESCs can bemaintained in the absence of serum using defined
conditions that include two kinase inhibitors (2i) (Ying et al.,
2008). PD0325901 (PD) inhibits the function of mitogen-acti-
vated protein kinase kinase (MAPKK), thereby inhibiting the Erk
signaling cascade, and CHIR99021 (CHIR) selectively targets
glycogen synthase kinase-3 (GSK3), resulting in an enforcement
of canonical Wnt signaling. This ‘‘2i state’’ of so-called naive plu-
ripotency has been shown to be very distinct in its transcriptional
and epigenetic profiles from ESCs cultured in serum/LIF (Habibi462 Cell Stem Cell 17, 462–470, October 1, 2015 ª2015 Elsevier Inc.et al., 2013; Marks et al., 2012). The state is marked by the spe-
cific upregulation of genes involved in metabolism and stem cell
maintenance, while developmental- and differentiation-associ-
ated genes become more repressed (Marks et al., 2012). The
observed differences in the transcriptional state further coincide
with drastic changes in the epigenetic landscape of the cells, i.e.,
a reduction of H3K27me3 at bivalent gene promoters and a
global loss of DNA methylation (Ficz et al., 2013; Habibi et al.,
2013; Marks et al., 2012).
Another hallmark of the 2i transition is the more homogenous
distribution of NANOG protein, switching from fluctuating (lower
and higher) levels under serum conditions to increased expres-
sion and more uniform protein distribution under 2i conditions
(Silva et al., 2009), pointing to a possible stabilization and rein-
forcement of the core pluripotency circuitry in 2i. Although it
is known that the pluripotent state is highly dependent on the
intrinsic gene regulatory network centered around the core
pluripotency factors OCT4, SOX2, and NANOG (OSN) (Chen
et al., 2008; Kim et al., 2008) and that cell state transitions involve
the remodeling of the core network (Buecker et al., 2014; Chan
et al., 2013), little is known about the specific impact that the
two inhibitors have on the OSN target spectrum.
Given the broad interest in the 2i state and the dramatic
cellular state changes that are induced through the inhibitors,
we decided to investigate the effects on OSN binding and study
their behavior early under the distinct culture conditions. To cap-
ture putative regulatory events upstream of major transcriptional
and epigenetic dynamics, we focused on mESCs 24 hr after the
switch (serum/LIF to 2i/LIF, hereafter referred as ‘‘serum’’ and
‘‘2i’’) andmeasured gene expression, DNAmethylation, selected
histone modifications, and OSN binding. Integrative analysis of
this multi-layered dataset together with select functional valida-
tion experiments including enhancer activity assays and PRC2
mutant ESCs provides new mechanistic insights that advance
our understanding of this unique cellular state.RESULTS
Reorganization of Core Pluripotency Factor Binding
in the Early 2i Transition
Several recent studies have highlighted the transcriptional
and epigenetic dynamics between cells in serum versus 2i
(Ficz et al., 2013; Marks et al., 2012). Notably, the induction
and repression of selected factors (e.g., Prdm14 and Dnmt3a/
3b) has been reported as early as 24 hr after addition of the
two inhibitors, pointing to a rapid transition of the ESC transcrip-
tome (Ficz et al., 2013). Using RNA sequencing we were able to
identify 1,013 genes that significantly changed their expression
in the initial 2i transition (24 hr 2i) and partially overlapped with
the 1,413 altered genes in the 2i population after three passages
(3P) (Figure S1A, Table S1). We grouped the differentially ex-
pressed genes across all three conditions into six clusters (Fig-
ure 1A, Figure S1B). This clustering captures recently described
dynamics such as the downregulation of Otx2 and the upregula-
tion of Klf2 (Yang et al., 2014; Yeo et al., 2014). Genes with
moderate but not yet significant expression changes in the initial
transition (cluster 2 and 5) encompass factors such as Prdm14
and Eras, which become highly divergent later in the transition
(Figure S1B). Overall, nearly half of the genes that become
repressed in 2i and a quarter of genes that become upregulated
in 2i already show altered expression within the first 24 hr
(Figure 1B). Oct4 and Sox2 show little expression change upon
switching conditions, while Nanog expression increases by
around 1.5-fold (Figure S1C). It is worth noting that besides
Nanog, we find several other pluripotency-related genes that
are differentially expressed in the initial 2i transition, including
Dppa3 and Utf1 at the extremes (Figure 1C). Utilizing our previ-
ously established Utf1-mCitrine reporter line (Galonska et al.,
2014), we confirmed that Utf1 is rapidly and uniformly repressed
upon being switched to 2i (Figure 1D). Additionally, STELLA and
NANOGappearmore homogenously distributed across the pop-
ulation already within the first 24 hr in 2i (Figure 1E).
To gain more mechanistic insights into the early regulatory
events, we analyzed the genome-wide binding patterns of
OSN under both conditions. To be able to quantify both new
and altered binding patterns, we utilized established, state-
of-the-art analytical methods, based on a negative-binomial
model and variance pooling as implemented in the publically
available software packages diffbind (http://bioconductor.org/
packages/release/bioc/html/DiffBind.html) and DESeq2 (http://
bioconductor.org/packages/release/bioc/html/DESeq2.html).
Using this approach, we find that all three factors become
subject towidespread binding rearrangements, with 14,796 sites
exhibiting differential NANOG binding, 1,352 sites with differen-
tial SOX2 binding, and 503 sites with differential OCT4 binding
with a minimal 2-fold change at a false discovery rate (FDR)
of 0.1 (NANOG and SOX2) or a p % 0.05 (OCT4) (Figure 1F,
Table S2). Clustering these regions reveals mostly coordinated
binding changes for all three factors (Figure 1F). It should be
noted that many of the observed binding changes were subtler
for OCT4 and SOX2, thereby frequently falling below our
threshold criteria for differential binding sites (Figure 1F, Fig-
ure S1D). Importantly, the majority of differentially enriched
NANOG and SOX2 binding sites are shared between 24 hr and
3P (Figure S1E), suggesting that early binding changes are
largely maintained. Gene ontology analysis shows that differen-
tially bound sites are enriched for biological processes associ-
ated with development and differentiation (Table S3), in line
with OSN’s known targeting of developmental genes in serum
(Kim et al., 2008).
Analysis of H3K4me3 and H3K27me3 patterns showed that
the majority of genomic sites with altered OSN binding areCedistinct from the sites that show dynamics for these two histone
modifications (Figure 1F). This observation is largely expected
based on our observations that the core pluripotency factors
are more frequently found at distal putative regulatory sites
(Gifford et al., 2013; Ziller et al., 2013), while H3K4me3 and
H3K27me3 can be found primarily at promoters or intragenic
regions (Figure 1G). While initially less dynamic, H3K4me3 and
H3K27me3 are further reorganized at later stages of the transi-
tion (Figure S1F). To evaluate if the observed OSN binding
changes in 2i are indeed state-specific rather than the result of
transitioning to a more homogenous cell population, we utilized
a NANOG GFP reporter line whose serum population consists of
a heterogeneous mixture of GFP-negative and GFP-positive
cells. Next, we isolated the GFP-positive population in serum
(Figure S1G) and compared its NANOG binding pattern to that
of the 2i population. Although a fraction of binding sites changed
between the whole serum population and the GFP-positive sub-
population, the global rewiring that occurs in the 2i transition was
not seen. Thus, the GFP-positive fraction exhibited equally many
binding changes to the 2i state as the whole serum population
(Figure S1H). This is in agreement with previous results showing
that the transcriptome of REX1-positive sorted serum cells is still
highly divergent from the homogenous REX1-positive 2i popula-
tion (Marks et al., 2012).
Lastly, to assess the effect of the reconfigured binding on
transcription in more detail, we correlated differential binding
with expression of the nearest gene (%50Kb of transcriptional
start site [TSS]). A large fraction of all differentially expressed
genes in 2i are bound by at least one of the three factors in
serum (Figure S1I). Specifically, 46% of all upregulated genes
and 29% of all downregulated genes exhibit a differential
OSN binding pattern after 24 hr in 2i (Figure 1H). However,
considering the number of differentially bound sites and differ-
entially expressed genes, this association is not statistically sig-
nificant in all cases: while genes repressed upon transition to 2i
were enriched for OSN sites that show decreased binding in 2i,
upregulated genes were equally enriched for sites with lower
and higher OSN binding (Figure S1J).
Differentially Bound Sites Are Enriched at Distal Gene
Regulatory Elements
Our analysis points toward an enrichment of dynamic regions at
distal putative regulatory sites, which is in line with two recent
studies showing that the transition to alternative pluripotent
states (e.g., 2i to EpiSCs) is accompanied by remodeling of
the cellular enhancer landscape (Buecker et al., 2014; Factor
et al., 2014). A well-known example for differential enhancer
use in primed versus naive pluripotency is the switch from the
Oct4 proximal (serum) to the distal (2i) element (Tesar et al.,
2007). Although we do not observe a complete switch in binding
between these elements, we find that the proximal enhancer
shows decreased NANOG binding upon being switched to 2i,
while the distal enhancer showed a small increase in SOX2
(Figure 2A).
Todetermine thepossible effects of differential binding,wefirst
assessed the activity of several enhancer elements in serum and
2i using a luciferase-based reporter assay. As expected, the
proximal enhancer showsdiminishedactivity in 2i,while thedistal
enhancer element clearly gained activity (Figure 2B). We thenll Stem Cell 17, 462–470, October 1, 2015 ª2015 Elsevier Inc. 463
A B
Up: 291
Down: 212
Up: 575
Down: 777
Up: 6870
Down:7926
Up: 472
Down:1286
Up: 450
Down: 822
OCT4SOX2 NANOG H3K4me3 H3K27me3
F
se
ru
m
24
h 
2i
2
0
-2
-4
lo
g 2
(fo
ld
 c
ha
ng
e 
se
ru
m
 v
s.
 2
4 
hr
 2
i)
D
−2
−1
0
1
2
se
ru
m
24
h 
2i
se
ru
m
24
h 
2i
se
ru
m
24
h 
2i
se
ru
m
24
h 
2i
H3K27me3H3K4me3NANOGOCT4SOX2
Other
Promoter
Enhancer
G
20
40
60
80
100
0
0 102 103 104 105
STELLA NANOGHoechst HoechstOverlay Overlay
E
serum24h 2i
mCitrine intensity
−1 0 1
C
ce
ll 
co
un
ts
0.5-0.5
z-score log2 count
24h 2i
serum
24h 2i
z-
sc
or
e 
lo
g 2
 c
ou
nt
U
tf1
D
pp
a2
Li
n2
8a
S
al
l4
D
pp
a4
Fo
xd
3
Li
n2
8b
Zf
p2
81
E
ra
s
Zf
x
Tr
im
28
Zf
p4
2
O
ct
4
Tc
l1
G
df
3
Tb
x3
S
ta
t3
M
bd
3
Tc
f3
Fb
ox
15
S
ox
15
N
r5
a2
D
pp
a5
a
K
lf2
N
an
og
D
pp
a3
3P 24h
3P 24h
n=299
n=202
Down in 2i
Up in 2i
serum 24h 2i 3P 2i
expression 
down in 3P 2i
expression 
up in 3P 2i
1
2
3
4
5
6
Myc
Id1
Eras
Otx2
Prdm14
Klf2
log2(FPKM+1) serum
lo
g 2
(F
P
K
M
+1
) 2
4h
 2
i
Diff expressed, diff binding
Diff expressed, no diff binding
H
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
(29%)
(46%)
Figure 1. Globally Reconfigured Binding of the Core Pluripotency Factors in the Early 2i Transition
(A) Expression data (z score log2 count) for cells cultured in serum, 24 hr 2i, or three passages 2i (3P). Only genes with FPKM> 1 in at least one of the conditions are
shown.
(B) Venn diagrams showing the overlap between all significantly downregulated and upregulated genes in 24 hr 2i versus serum as compared to 3P 2i versus
serum.We find an overlap of 299 downregulated genes (47% relative to 3P set) and 202 upregulated genes (26% relative to 3P set) between 24 hr in 2i and 3P in 2i.
Diagrams are drawn to scale.
(C) Expression (log2 fold change) of pluripotency-associated transcription factors in serum versus 24 hr 2i. The error bars represent one SE over two biological
replicates.
(D) FACS sorting showing the fluorescent intensity of Utf1-mCitrine reporter cells in serum versus 24 hr 2i. On the right: images of the reporter cell line in serum and
after switching cells to 24 hr 2i. Scale bar, 150 mm.
(E) Immunofluorescent pictures of STELLA and NANOG in serum versus 24 hr 2i. Protein distributions of STELLA and NANOG become more homogenous after
24 hr in 2i. Scale bar, 80 mm.
(F) Heatmap showing all differential binding sites (z score log2 count) for SOX2,OCT4, NANOG, H3K4me3, andH3K27me3 in serum and 24 hr 2i. Numbers ofmore
highly (up) and less (down) enriched sites are shown below.
(G) Pie charts illustrating the proportion of differentially enriched SOX2, OCT4, NANOG, H3K4me3, and H3K27me3 sites that overlap with promoters (±1 kb of
TSS) or enhancers based on previously published p300 binding sites in mESCs in serum (Creyghton et al., 2010). All regions not overlapping with either one of
these two were classified as other regions.
(H) Scatterplot showing all significantly up- and downregulated genes after 24 hr 2i that are (orange dots) or are not (black dots) differentially bound by OCT4,
SOX2, or NANOG. 29% of the upregulated genes in 2i become differentially bound by the core factors (left pie chart) and 46% of all downregulated genes in 2i
become differentially bound by the core factors (right pie chart).
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Figure 2. Differential OSN Binding Can Be Linked to Differential Enhancer Activity in 2i
(A) ChIP-seq tracks showing the binding of NANOG, SOX2, OCT4, and p300 in serum and 24 hr 2i (p300 only in serum) along theOct4 proximal (PE) and distal (DE)
enhancer elements. Serum and 24 hr 2i ChIP-seq tracks are scaled to the same height for each factor and locus. Differentially bound regions for NANOG and
SOX2 are highlighted in gray. Regions tested in the luciferase assay (B) are displayed as red boxes. Presence of OSN binding motifs are indicated as circles.
Green circles, SOX2; blue circles, OCT4. Number of circles indicates the frequency of the motif.
(B) Top: relative Luciferase activity of the Oct4 proximal (PE) and distal (DE) enhancer elements in serum and 24 hr 2i (n = 3). The empty pGL4.24 plasmid
(Promega) was used as control (ctrl). Bottom: relative Luciferase activity of theOct4 proximal (PE) and distal (DE) enhancer elements in serum as compared to the
scrambled elements in 24 hr 2i. The empty pGL4.24 plasmid (Promega) was used as control (ctrl). The number of scrambled nucleotides targeting the OSNmotifs
and total length of the total tested elements are shown on the right. Error bars represent one SD over three technical replicates.
(C) ChIP-seq tracks showing the binding of NANOG, SOX2, OCT4, and p300 along the Utf1, Jarid2 (enhancer 1 and 2), Fgf5, and Prdm14 enhancer elements in
serum and 24 hr 2i (p300 only in serum). Serum and 24 hr 2i ChIP-seq tracks are scaled to the same height for each factor and locus. Regions tested in the
luciferase assay (D and E) are displayed as red boxes. Differentially bound regions for NANOG, SOX2, andOCT4 are highlighted in gray. Presence of OSN binding
motifs are indicated as circles. Green circles, SOX2; blue circles, OCT4; and yellow circles, NANOG. Number of circles indicates the frequency of the motif.
(D) Relative Luciferase activity of theUtf1, Jarid2 (enhancer 1 and 2), Fgf5, andPrdm14 enhancer elements in serum and 24 hr 2i. The empty pGL4.24 plasmid was
used as control (ctrl). Error bars represent one SD over three technical replicates.
(E) Relative Luciferase activity of the Utf1, Jarid2 (enhancer 1 and 2), Fgf5, and Prdm14 enhancer elements in serum as compared to the disrupted elements in
24 hr 2i. The empty pGL4.24 plasmid was used as control (ctrl). The number of scrambled nucleotides and total length of the tested elements are shown on the
right. Error bars represent one SD over three technical replicates.replaced identified OSN motifs with a scrambled sequence (see
Experimental Procedures) and found that the activity of the ele-
ments was greatly impaired (Figure 2B, Figure S2A). To expand
these findings, we next tested additional targets including Utf1
and Jarid2 (enhancer 1) as examples with no differential binding,
Fgf5 as an example of lower NANOG binding in 2i, and Prdm14
and Jarid2 (enhancer 2) representative of increased OSN binding
(Figure 2C). In general we found that differential OSN binding
was associated with altered activity of the tested elements in 2i
(Figure 2D) and that all elements exhibited impaired activity
upon disruption of the identified binding motifs (Figure 2E).CeNotably, control regions (no p300 enrichment in serum) did not
alter their activity in 2i, and in the case of the Otx2 promoter,
the disruption of the OSN binding sites had no apparent effect
on the activity either (Figures S2B and S2C).
OSN Rewiring Precedes the Global Loss of DNA
Methylation in 2i
We next wanted to explore possible mechanisms that could lead
to the global reorganization in transcription factor binding. As
shown earlier H3K4me3 and H3K27me3 dynamics showed little
overlap with changes in the OSN binding pattern (Figure 1F). Asll Stem Cell 17, 462–470, October 1, 2015 ª2015 Elsevier Inc. 465
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Figure 3. OSN Rewiring Precedes Global
DNA Demethylation and Overlaps with
Motifs of Factors Linked to Wnt and Erk
Signaling
(A) DNA methylation levels of differentially bound
OCT4, SOX2, and NANOG sites under serum
conditions. Error bars represent one SD.
(B) Histograms showing the global DNA methyl-
ation distribution in mESCs (serum and 24 hr 2i).
(C) DNA methylation levels of differentially bound
OCT4, SOX2, and NANOG sites in serum versus
24 hr 2i. Error bars represent one SD.
(D) Transcription factor motifs that are enriched
in regions with increased binding for NANOG or
SOX2 in 24 hr 2i. Transcription factors that are
implicated in Wnt signaling are highlighted in
green.Motifs exemplary for OTX2, LEF1, and DLX4
are shown.
(E) Transcription factor motifs that are enriched
in regions with increased binding for NANOG or
SOX2 in serum. Transcription factors that are
implicated in Erk signaling are highlighted in red.
Motifs exemplary for ZFP423 and EGR1/2 are
shown.
(F) Expression (log2 fold change) of transcription
factors in serum versus 24 hr 2i that were identified
as co-factors for sites with higher NANOG and
SOX2 binding in 2i. The error bars represent one
SE over two biological replicates.
(G) Expression (log2 fold change) of transcription
factors in serum versus 24 hr 2i that were identified
as co-factors for sites with higher NANOG and
SOX2 binding in serum. The error bars represent
one SE over two biological replicates.expected OSN sites that are bound in serum already exhibited
low levels of DNA methylation (Figure 3A); however, sites that
specifically gain OSN binding in 2i exhibit higher methylation
levels in serum. To test whether the change in methylation is a
cause or consequence of the differential binding, we measured
global DNA methylation in serum versus 2i (24 hr). Importantly,
in agreement with previous studies (Habibi et al., 2013; Ficz
et al., 2013), we could not yet detect a global decrease in DNA
methylation (Figure 3B). As a more site-specific loss of DNA
methylation might be obscured in the global DNA methylation
analysis, we next assessed the methylation status of regions
with differential OSN binding after 24 hr in 2i, but we did not
detect any change in DNAmethylation in this analysis either (Fig-
ure 3C). In contrast, when we used published whole-genome
bisulfite sequencing data to assess the intermediate transition
state (7 days in 2i) and the adapted 2i population (GEO:
GSE41923) we find that sites with a gain in OSN binding become
subject to a gradual loss of methylation (Figure S3A).466 Cell Stem Cell 17, 462–470, October 1, 2015 ª2015 Elsevier Inc.Differentially Bound OSN Sites
Co-Occur with Motifs Linked
to Wnt and Erk Signaling
Given the limited role of epigenetic modi-
fications, we next looked into the occur-
rence ofmotifs thatmight point to relevant
co-factors. We found that sites with
increased binding in 2i are enriched for
motifs corresponding to the transcriptionfactors LEF1 and TCF7, which are direct effectors of the Wnt
pathway (Reya and Clevers, 2005), as well as several HOX pro-
teins whose expression is modulated through this pathway (De-
schamps and van Nes, 2005) (Figure 3D). On the other hand,
sites with decreased binding in 2i were specifically enriched for
motifs of Erk pathway modulators, such as EGR1, SP1, and
KLF7 (Black et al., 2001; Gregg and Fraizer, 2011; Merchant
et al., 1999) (Figure 3E). Notably, several of the identified co-fac-
tors change their expression upon addition of the two kinase in-
hibitors (Figures 3F and 3G). This change in available co-factors
might therefore impact the propensity of OSN to preferentially
engage certain binding sites over others.
Transcriptional Silencing of Bivalent Genes Is
Independent of PRC2 Function in 2i
In line with previous reports (Marks et al., 2012), we find several
bivalent loci such as the HoxA cluster or Otx2 that exhibit
a gradual loss of H3K27me3 (Figures 4A and 4B). However,
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Figure 4. Transcriptional Silencing of Bivalent Genes Is Independent of PRC2 Function in 2i
(A) ChIP-seq tracks for H3K27me3 along theHoxA cluster in serum, 24 hr 2i, and 3P 2i, as well as RNA-seq tracks for serum and 3P 2i. Read counts are normalized
to 1 million reads.
(B) ChIP-seq tracks for H3K27me3 along the Otx2 gene locus in serum, 24 hr 2i, and 3P 2i, as well as RNA-seq tracks for serum and 3P 2i. Read counts are
normalized to 1 million reads.
(C) Differentially enriched 1 kb tiles for H3K27me3 and H3K4me3 in serum versus 24 hr 2i. Bivalent loci are highlighted in black.
(D) Differentially enriched 1 kb tiles for H3K27me3 and H3K4me3 in serum versus 3P 2i. Bivalent loci are highlighted in black.
(E) Number of bivalent genes in serum, 24 hr 2i, and 3P 2i. Only 55% of genes that are bivalent in serum retain their bivalent status after 24 hr in 2i, which further
decreases to 40% after 3P in 2i.
(F) Expression (log2(FPKM)) for a selection of lineage markers in WT and Eed mutant cells in serum versus three passages 2i (3P). The transcriptional changes
coincide with a decrease of H3K27me3 deposition along the promoter regions of the genes, as shown for the Otx2, Gata4, and Bmp6 locus. The error bars
represent one SE over two biological replicates.
(legend continued on next page)
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both also show decreased H3K4me3 (Figures S4A and S4B) as
reported previously (Gafni et al., 2013). When we plotted the
global enrichment level of both histone modifications in serum
versus 2i, we observed a general shift to lower enrichment for
H3K4me3 at bivalent gene loci in the initial 2i transition, and
this shift is largely maintained (Figures 4C and 4D). On the other
hand, the repressive H3K27me3 mark shows a more subtle
shift to lower enrichment within the first 24 hr in 2i, which be-
comes more pronounced after three passages. ChIP-qPCR
further confirmed these subtle differences for H3K27me3 within
the first 24 hr in 2i (Figure S4C). The faster H3K4me3 dynamics
compared to H3K27me3 in this context are similar to observa-
tions in reprogramming (Koche et al., 2011). Overall, only 55%
of all bivalent genes in serum retain their bivalent status after
24 hr in 2i and even fewer (40%) do so after three passages
(Figure 4E, Table S4). However, similar to the HoxA cluster
and Otx2, the differential enrichment of these histone marks
seems to have little impact on the expression of associated
genes (Figure S4D). This is consistent with previous reports
showing that the basal expression level of many bivalent genes
remains the same or is even further downregulated in 2i (Marks
et al., 2012).
To better understand the relevance of H3K27me3 repression,
we used an Eed mutant ESC line that is devoid of H3K27me3
(Montgomery et al., 2005) (Figure S4E). Under serum conditions,
Eed-deficient cells are extremely unstable and display aberrant
expression of differentiation-associated genes (Figure 4F), high-
lighting the importance of PRC2 function as a balancing factor in
the metastable serum state (Boyer et al., 2006; Montgomery
et al., 2005). However, when switched to 2i, the cells exhibited
a complete morphologic and molecular stabilization, reflected
by the abrogation of spontaneous differentiation and associated
expression of differentiation genes (Figures 4F and 4G). Addi-
tionally, we find that Utf1 and Tcf15 de novo silencing—two
genes that gain H3K27me3 early in the 2i transition—is unaf-
fected despite the absence of H3K27me3 (Figures 4H and 4I).
The same independence of PRC2-mediated silencing was
observed in Eed knockdown cells (Figures S4F and S4G). There-
fore the establishment of a repressed chromatin structure at the
Utf1 and Tcf15 loci, albeit rapid in WT cells, can be interpreted
as a secondary event in their transcriptional downregulation.
To assess the generality of this finding, we generated RNA-seq
data for Eed mutant cells in serum versus 2i (3P) and compared
the expression profiles to those of theWT cells in serum versus 2i
(3P). Interestingly, we find that PRC2-independent gene regula-
tion is not limited to the loci mentioned above as the majority of
differentially expressed genes becomes similarly induced or
repressed in the absence of H3K27me3 (Figures S4H and S4I).
Focusing on the differential expression of bivalent genes con-
firms this trend even further. The maintained or enforced repres-
sion of bivalent genes that lose their bivalent state in 2i (Table S4)(G) Morphologic stabilization of Eed mutant cells in 2i. The cells exhibit a tight m
Scale bar, 100 mm.
(H) ChIP-seq tracks for H3K27me3 and H3K4me3 along the Utf1 and Tcf15 locus
(I) Expression (log2(FPKM) ofUtf1 and Tcf15 in serum versus 3P 2i in theWT and E
(J) Violin plot showing the average expression (log2(FPKM) for bivalent genes tha
and in the Eed mutant line in serum and 2i (3P). Note that the average expressio
passages in 2i.
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PRC2 complex in 2i (Figure 4J).
Lastly, it has been shown that the protein PRDM14, a
PR-domain-containing transcriptional regulator, is upregulated
under 2i conditions and subsequently negatively regulates
Dnmt3a and Dnmt3b expression (Leitch et al., 2013; Yamaji
et al., 2013). Moreover, a previously published expression data-
set suggests a negative correlation between the presence of
PRDM14 and Utf1 expression (Yamaji et al., 2013), which poten-
tially accounts for the latter’s repression in 2i. Again, as for WT
cells, we detected a clear upregulation of Prdm14 in the Eed
mutant cells switched to 2i (Figure S4J). The previously postu-
lated model suggested that PRDM14 exerts its repressive
function through a direct recruitment of PRC2 to its target sites.
However, we find that H3K27me3-deficient cells demonstrate
uncompromised repression of Dnmt3a/3b as well as Utf1,
suggesting that PRDM14 can either exert its function directly
as a signaling regulator or operate through a different repressive
mechanism (Figure 4I and Figure S4J). Taken together, these
findings render PRC2-dependent dynamics of H3K27me3 a
negligible variable in the explanation of transcriptional reconfigu-
ration upon the transition to 2i.
DISCUSSION
The stable transition from serum/LIF to the 2i condition is asso-
ciated with global transcriptional and epigenetic changes in
ESCs. Key events in this transition constitute the upregulation
of metabolism-associated genes, the downregulation of devel-
opmental-associated genes, and global hypomethylation of
the cells, as well as a decline of the repressive histone mark
H3K27me3 (Marks et al., 2012). Although a more homogenous
distribution of NANOG points to a possible stabilization and
reinforcement of the core pluripotency circuitry in 2i, the bind-
ing of the core pluripotency factors, OSN, in the transition to 2i
have not been studied in detail. To fill this mechanistic gap, we
focused on ESCs 24 hr after the switch and mapped the bind-
ing pattern of the core pluripotency factors OSN as well as the
differential enrichment of the activating and repressive histone
marks H3K4me3 and H3K27me3. While the core pluripotency
factors show only moderate (Nanog) to no (Oct4 and Sox2)
differential expression in 2i, we detected a globally reconfig-
ured binding pattern for all three factors after only 24 hr in 2i,
highlighting their high sensitivity to altering ESC culturing con-
ditions. Importantly, the early rewiring of OSN is largely main-
tained throughout the 2i transition and precedes the majority
of changes in the enrichment of the bivalent chromatin marks
H3K4me3 and H3K27me3 as well as the global loss of DNA
methylation.
Although we find over one-third of all differentially expressed
genes to be differentially bound in 2i, the overall correlation isorphology together with the abrogation of spontaneous differentiation in 2i.
in serum and after 24 hr in 2i. Read counts are normalized to 1 million reads.
edmutant cells. The error bars represent one SE over two biological replicates.
t lose their bivalent state both in 3P 2i (Table S4) in the WT in serum and 2i (3P)
n of bivalent genes decreases for the WT and the Eed mutant cells after three
rather weak as the majority of differential binding events are not
associated with expression changes. This result may not be that
surprising as only a small subset of OSN-engaged genes are
known to be bona fide targets while the majority are not affected
by the depletion of any of the factors (Loh et al., 2006). Notably,
this is a common phenomenon observed for transcription factors
in higher eukaryotes where usually only 10%–25% of TF occu-
pancy can be linked to expression of neighboring genes (Spitz
and Furlong, 2012). Attributes that predict functional binding
events are the presence of strong binding motifs and TF binding
events at active enhancer elements (Cusanovich et al., 2014).
Indeed, we find that the differential binding of the core pluripo-
tency factors along key enhancer elements—but not at non-
enhancer elements—correlates with their activity in 2i and that
the disruption of identified OSN motifs results in a complete
loss of enhancer activity. Although TF binding alone is not
necessarily indicative of transcriptional activity, it might label re-
gions that will be used subsequently, e.g., by stage-specific TFs
(Spitz and Furlong, 2012). These priming events may therefore
facilitate developmental transitions by reducing the rate-limiting
step of chromatin remodeling. Interestingly, we find that differen-
tial binding sites are enriched for TF motifs associated with ca-
nonical Wnt signaling and the Erk pathway, the main signaling
cascades perturbed through the inhibitors CHIR andPD, respec-
tively. Specifically, sites with higher NANOGand SOX2 binding in
2i are enriched for motifs of TFs implicated in the 2i-enhanced
Wnt signaling pathway, while sites with lower binding share
motifs of cofactors involved in the differentiation-associated
Erk signaling pathway, which is repressed in 2i. Thus, binding/
priming of genes connected to differentiation is maintained in a
metastable serum state, yet seems to be less crucial under
enforced pluripotency conditions, where the engagement shifts
to maintaining the pluripotent state.
Besides the rewiring of the core pluripotency network in 2i, we
find that the divergent enrichment of the histone modifications
H3K4me3 and H3K27me3 does not account for the majority of
observed transcriptional variance in 2i. Moreover, H3K27me3-
deficient Eed mutant cells induce normal repression of genes
such asUtf1 and Tcf15 in 2i andmaintained the silencing of biva-
lent loci. This dispensable function of PRC2 function in 2i is
in contrast to the metastable serum/LIF state, which is highly
dependent on proper PRC2 for maintenance of the pluripotent
state (Geula et al., 2015). This apparent PRC2 independence in
2i is even more intriguing considering that this transition is also
accompanied by global DNA hypomethylation (Ficz et al.,
2013; Habibi et al., 2013). Therefore, 2i pluripotency—a state
shielding ESCs from differentiation-inducing signals—appears
to function in the absence of H3K27me3 and DNA methylation,
both of which are generally regarded as key repressive epige-
netic regulators in the metastable serum state. While more
work remains to be done, our results further contribute to the
understanding of the 2i state and regulation of pluripotency in
general.EXPERIMENTAL PROCEDURES
Cell Culture
mESCs were cultured in regular media containing 15% FBS, 1% PEN/STREP,
1% glutamine, 1% NEAA, and 5 3 105 U LIF. For ESC maintenance dishesCewere coated with 0.2% gelantin and irradiated CF1 mouse embryonic fibro-
blasts (MEFs) were plated as a confluent layer of feeder cells. ESCs were
seeded in a density of 50,000 cells/6 wells and were split every 2–3 days.
The 2i media was prepared according to the protocol of Ying et al. (2008)
and was supplemented with 5 3 105 U LIF.
Antibodies
ChIP was performed using the following antibodies at a final concentration of
1 mg/13106 cells: H3K4me3 (Millipore, 07-473), H3K27me3 (Millipore, 07-449),
OCT4 (Santa Cruz, sc-8628 X), SOX2 (Santa Cruz, sc-17320 X), and NANOG
(Cosmo Bio Ltd, REC-RCAB0002P-F). Immunostaining was done with the
following primary antibodies, all diluted 1:1,000: NANOG (BD, 560259) and
STELLA (Santa Cruz, sc-67249). Western blots were done using the following
antibodies: UTF1 (1:1,000; Abcam, ab24273), Histone H3 (1:5,000; Abcam,
ab61251), and EED (Abcam, ab4469).
ChIP
Cells were crosslinked in 1% formaldehyde for 15min (5min for UTF1 Antibody
and UTF1-BioChIP) at room temperature, with constant agitation, and
quenched with 125mM glycine for 5 min at room temperature. Nuclei were iso-
lated and chromatin was sheared using Branson sonifier until the majority
of DNA was in the range of 200–700 base pairs. Chromatin was incubated
with antibody overnight at 4C, with constant agitation. Immunoprecipitation
of antibody-protein complexes was completed using Protein A or Protein G
Dynabeads (Invitrogen) for 2–3 hr at 4C, with constant agitation.
ACCESSION NUMBERS
The accession number for the ChIP-seq and RNA-seq data reported in this
paper is GEO: GSE56312.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes four figures, four tables, and
Supplemental Experimental Procedures and can be found with this article
online at http://dx.doi.org/10.1016/j.stem.2015.07.005.
AUTHOR CONTRIBUTIONS
C.G. conducted the experiments; C.G., M.Z., and A.M. conceived and de-
signed the experiments; M.Z. performed computational analysis of ChIP-seq
data; and R.K. performed computational analysis of RNA-seq and RRBS
data. C.G., M.Z., and A.M. wrote the paper.
ACKNOWLEDGMENTS
Wewould like to thankRobbyn Issner,HollyWhitton, andHongcangGu for their
advice and support regarding the ChIP-seq library preparation. A.M. is a New
York Stem Cell Foundation, Robertson Investigator. This work was funded
by the Human Frontiers Science Program, NIH grants 1P50HG006193 and
P01GM099117, and the New York Stem Cell Foundation.
Received: March 12, 2014
Revised: March 25, 2015
Accepted: July 8, 2015
Published: July 30, 2015
REFERENCES
Black, A.R., Black, J.D., and Azizkhan-Clifford, J. (2001). Sp1 and kru¨ppel-like
factor family of transcription factors in cell growth regulation and cancer.
J. Cell. Physiol. 188, 143–160.
Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I.,
Levine, S.S., Wernig, M., Tajonar, A., Ray, M.K., et al. (2006). Polycomb com-
plexes repress developmental regulators in murine embryonic stem cells.
Nature 441, 349–353.ll Stem Cell 17, 462–470, October 1, 2015 ª2015 Elsevier Inc. 469
Buecker, C., Srinivasan, R., Wu, Z., Calo, E., Acampora, D., Faial, T., Simeone,
A., Tan, M., Swigut, T., and Wysocka, J. (2014). Reorganization of enhancer
patterns in transition from naive to primed pluripotency. Cell Stem Cell 14,
838–853.
Chan, Y.S., Go¨ke, J., Ng, J.H., Lu, X., Gonzales, K.A., Tan, C.P., Tng, W.Q.,
Hong, Z.Z., Lim, Y.S., and Ng, H.H. (2013). Induction of a human pluripotent
state with distinct regulatory circuitry that resembles preimplantation epiblast.
Cell Stem Cell 13, 663–675.
Chen, X., Xu, H., Yuan, P., Fang, F., Huss,M., Vega, V.B.,Wong, E., Orlov, Y.L.,
Zhang, W., Jiang, J., et al. (2008). Integration of external signaling pathways
with the core transcriptional network in embryonic stem cells. Cell 133,
1106–1117.
Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W.,
Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., et al.
(2010). Histone H3K27ac separates active from poised enhancers and pre-
dicts developmental state. Proc. Natl. Acad. Sci. USA 107, 21931–21936.
Cusanovich, D.A., Pavlovic, B., Pritchard, J.K., and Gilad, Y. (2014). The func-
tional consequences of variation in transcription factor binding. PLoS Genet.
10, e1004226.
Deschamps, J., and van Nes, J. (2005). Developmental regulation of the Hox
genes during axial morphogenesis in the mouse. Development 132, 2931–
2942.
Factor, D.C., Corradin, O., Zentner, G.E., Saiakhova, A., Song, L., Chenoweth,
J.G., McKay, R.D., Crawford, G.E., Scacheri, P.C., and Tesar, P.J. (2014).
Epigenomic comparison reveals activation of ‘‘seed’’ enhancers during transi-
tion from naive to primed pluripotency. Cell Stem Cell 14, 854–863.
Ficz, G., Hore, T.A., Santos, F., Lee, H.J., Dean, W., Arand, J., Krueger, F.,
Oxley, D., Paul, Y.L., Walter, J., et al. (2013). FGF signaling inhibition in
ESCs drives rapid genome-wide demethylation to the epigenetic ground state
of pluripotency. Cell Stem Cell 13, 351–359.
Gafni, O., Weinberger, L., Mansour, A.A., Manor, Y.S., Chomsky, E., Ben-
Yosef, D., Kalma, Y., Viukov, S., Maza, I., Zviran, A., et al. (2013). Derivation
of novel human ground state naive pluripotent stem cells. Nature 504,
282–286.
Galonska, C., Smith, Z.D., and Meissner, A. (2014). In Vivo and in vitro dy-
namics of undifferentiated embryonic cell transcription factor 1. Stem Cell
Reports 2, 245–252.
Geula, S., Moshitch-Moshkovitz, S., Dominissini, D., Mansour, A.A., Kol, N.,
Salmon-Divon, M., Hershkovitz, V., Peer, E., Mor, N., Manor, Y.S., et al.
(2015). Stem cells. m6A mRNA methylation facilitates resolution of naı¨ve plu-
ripotency toward differentiation. Science 347, 1002–1006.
Gifford, C.A., Ziller, M.J., Gu, H., Trapnell, C., Donaghey, J., Tsankov, A.,
Shalek, A.K., Kelley, D.R., Shishkin, A.A., Issner, R., et al. (2013).
Transcriptional and epigenetic dynamics during specification of human em-
bryonic stem cells. Cell 153, 1149–1163.
Gregg, J., and Fraizer, G. (2011). Transcriptional Regulation of EGR1 by EGF
and the ERK Signaling Pathway in Prostate Cancer Cells. Genes Cancer 2,
900–909.
Habibi, E., Brinkman, A.B., Arand, J., Kroeze, L.I., Kerstens, H.H., Matarese,
F., Lepikhov, K., Gut, M., Brun-Heath, I., Hubner, N.C., et al. (2013). Whole-
genome bisulfite sequencing of two distinct interconvertible DNA methylomes
of mouse embryonic stem cells. Cell Stem Cell 13, 360–369.
Kim, J., Chu, J., Shen, X., Wang, J., and Orkin, S.H. (2008). An extended tran-
scriptional network for pluripotency of embryonic stem cells. Cell 132, 1049–
1061.470 Cell Stem Cell 17, 462–470, October 1, 2015 ª2015 Elsevier Inc.Koche, R.P., Smith, Z.D., Adli, M., Gu, H., Ku, M., Gnirke, A., Bernstein, B.E.,
and Meissner, A. (2011). Reprogramming factor expression initiates wide-
spread targeted chromatin remodeling. Cell Stem Cell 8, 96–105.
Kunath, T., Saba-El-Leil, M.K., Almousailleakh, M., Wray, J., Meloche, S., and
Smith, A. (2007). FGF stimulation of the Erk1/2 signalling cascade triggers tran-
sition of pluripotent embryonic stem cells from self-renewal to lineage commit-
ment. Development 134, 2895–2902.
Leitch, H.G., McEwen, K.R., Turp, A., Encheva, V., Carroll, T., Grabole, N.,
Mansfield, W., Nashun, B., Knezovich, J.G., Smith, A., et al. (2013). Naive plu-
ripotency is associated with global DNA hypomethylation. Nat. Struct. Mol.
Biol. 20, 311–316.
Loh, Y.H., Wu, Q., Chew, J.L., Vega, V.B., Zhang, W., Chen, X., Bourque, G.,
George, J., Leong, B., Liu, J., et al. (2006). The Oct4 and Nanog transcription
network regulates pluripotency in mouse embryonic stem cells. Nat. Genet.
38, 431–440.
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H.,
Nichols, J., Kranz, A., Stewart, A.F., Smith, A., and Stunnenberg, H.G.
(2012). The transcriptional and epigenomic foundations of ground state plurip-
otency. Cell 149, 590–604.
Merchant, J.L., Du, M., and Todisco, A. (1999). Sp1 phosphorylation by Erk 2
stimulates DNA binding. Biochem. Biophys. Res. Commun. 254, 454–461.
Montgomery, N.D., Yee, D., Chen, A., Kalantry, S., Chamberlain, S.J., Otte,
A.P., and Magnuson, T. (2005). The murine polycomb group protein Eed is
required for global histone H3 lysine-27 methylation. Curr. Biol. 15, 942–947.
Reya, T., and Clevers, H. (2005). Wnt signalling in stem cells and cancer.
Nature 434, 843–850.
Silva, J., Nichols, J., Theunissen, T.W., Guo, G., van Oosten, A.L., Barrandon,
O., Wray, J., Yamanaka, S., Chambers, I., and Smith, A. (2009). Nanog is the
gateway to the pluripotent ground state. Cell 138, 722–737.
Spitz, F., and Furlong, E.E. (2012). Transcription factors: from enhancer bind-
ing to developmental control. Nat. Rev. Genet. 13, 613–626.
Tesar, P.J., Chenoweth, J.G., Brook, F.A., Davies, T.J., Evans, E.P., Mack,
D.L., Gardner, R.L., and McKay, R.D. (2007). New cell lines from mouse
epiblast share defining features with human embryonic stem cells. Nature
448, 196–199.
Yamaji, M., Ueda, J., Hayashi, K., Ohta, H., Yabuta, Y., Kurimoto, K., Nakato,
R., Yamada, Y., Shirahige, K., and Saitou, M. (2013). PRDM14 ensures naive
pluripotency through dual regulation of signaling and epigenetic pathways in
mouse embryonic stem cells. Cell Stem Cell 12, 368–382.
Yang, S.H., Kalkan, T., Morissroe, C., Marks, H., Stunnenberg, H., Smith, A.,
and Sharrocks, A.D. (2014). Otx2 and Oct4 drive early enhancer activation dur-
ing embryonic stem cell transition from naive pluripotency. Cell Rep. 7, 1968–
1981.
Yeo, J.C., Jiang, J., Tan, Z.Y., Yim, G.R., Ng, J.H., Go¨ke, J., Kraus, P., Liang,
H., Gonzales, K.A., Chong, H.C., et al. (2014). Klf2 is an essential factor that
sustains ground state pluripotency. Cell Stem Cell 14, 864–872.
Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J.,
Cohen, P., and Smith, A. (2008). The ground state of embryonic stem cell
self-renewal. Nature 453, 519–523.
Ziller, M.J., Gu, H., Mu¨ller, F., Donaghey, J., Tsai, L.T., Kohlbacher, O., De
Jager, P.L., Rosen, E.D., Bennett, D.A., Bernstein, B.E., et al. (2013).
Charting a dynamic DNA methylation landscape of the human genome.
Nature 500, 477–481.
